Skip to main content
Clinical Trials/NL-OMON21985
NL-OMON21985
Not Yet Recruiting
N/A

The effect of Peak Baby Preterm on growth, and status of DHA, Iron, vitamin D and vitamin A in apparently healthy Nigerian late preterm infants

Department of Pediatrics, College of Medicine University of Ibadan, Ibadan, Nigeria0 sites60 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Growth, nutritional status, apparently healthy late preterm infants, Nigeria, DHA, Iron, Vitamin A, Vitamin D
Sponsor
Department of Pediatrics, College of Medicine University of Ibadan, Ibadan, Nigeria
Enrollment
60
Status
Not Yet Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Department of Pediatrics, College of Medicine University of Ibadan, Ibadan, Nigeria

Eligibility Criteria

Inclusion Criteria

  • apparently healthy, appropriate for gestational age, on full enteral feeding, bottle (at least 50% at inclusion and 100% at age 4 weeks) or breastfed (at least 75% of daily milk intake) dependent on the study groups, being able and willing to drink milk, no medical recognized mental problems.

Exclusion Criteria

  • \>50% human milk at inclusion (for the formula group) or \>25% formula consumption (for the breastfed group), congenital malformations or conditions known to affect growth (e.g. severe broncho pulmonary dysplasia, inborn error of metabolism, cardiac or renal disease, necrotizing enterocolitis with substantial gut loss, and grade IV intraventricular hemorrhage), lactose intolerance, familiar history of impaired iron metabolism (haptoglobin Hp2\-2, hemochromatosis, sickelcell anemia, thalassemia). Medications that may effect digestion or absorption of food, medications that may affect sleep, blood transfusions, vitamin supplements during the intervention period.

Outcomes

Primary Outcomes

Not specified

Similar Trials